Cutter & Co Brokerage’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Cutter & Co Brokerage’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-29,750	Closed	-$2K	–	286
2021 Q3	$2K	Hold	29,750	–	–	﹤0.01%	304
2021 Q2	$2K	Hold	29,750	–	–	﹤0.01%	311
2021 Q1	$2K	Buy	29,750 +3,750	+14%	+$252	﹤0.01%	299
2020 Q4	$2K	Hold	26,000	–	–	﹤0.01%	280
2020 Q3	$2K	Hold	26,000	–	–	﹤0.01%	270
2020 Q2	$1K	Buy	+26,000	New	+$1K	﹤0.01%	244
2018 Q4	–	Sell	-28,500	Closed	-$2K	–	306
2018 Q3	$2K	Buy	+28,500	New	+$2K	﹤0.01%	282
2017 Q1	–	Sell	-79,500	Closed	-$2K	–	279
2016 Q4	$2K	Hold	79,500	–	–	﹤0.01%	252
2016 Q3	$8K	Sell	79,500 -5,000	-6%	-$1.09K	﹤0.01%	248
2016 Q2	$31K	Hold	84,500	–	–	0.01%	237
2016 Q1	$32K	Sell	84,500 -10,000	-11%	-$4.12K	0.01%	235
2015 Q4	$37K	Hold	94,500	–	–	0.02%	215
2015 Q3	$54K	Sell	94,500 -17,000	-15%	-$8.71K	0.03%	206
2015 Q2	$60K	Buy	111,500 +17,000	+18%	+$13.9K	0.02%	245
2015 Q1	$77K	Buy	94,500 +2,000	+2%	+$1.65K	0.03%	216
2014 Q4	$74K	Buy	+92,500	New	+$84.6K	0.03%	244

Other funds holding PVCT

Sunflower Bank Dallas, Texas $418M AUM 23.68% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

LDB

Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

ACM

Academy Capital Management Waco, Texas $699M AUM 12.08% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Cutter & Co Brokerage's PVCT Position: Q4 2021 in Review

Cutter & Co Brokerage sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2021, closing a stake of 29,750 shares — an estimated $2K sold.

Cutter & Co Brokerage first reported a position in PVCT in Q4 2014 and held it in 16 quarters. The position peaked at $77K in Q1 2015. 7 funds tracked by Wall St. Rank hold PVCT as of Q4 2021.

Cutter & Co Brokerage reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2021 after selling out during the quarter.
Cutter & Co Brokerage sold 29,750 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2021, an estimated $2K.
Cutter & Co Brokerage first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q4 2014 and held it in 16 quarters.
Cutter & Co Brokerage's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $77K in Q1 2015.
7 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2021.

Based on Cutter & Co Brokerage's 13F filing for Q4 2021, filed 10 Feb 2022.